Professor Glasziou, who was the director of Oxford University’s Centre for Evidence-Based from 2003 to 2010, is a general practitioner and an international leader in evidence-based medicine. He is the author of seven books related to evidence based practice, and has lead over 100 EBM workshops in dozens of countries. Now at Bond University in Australia, his research focuses on improving the clinical impact of publications by reducing the more than $85 Billion annual loss from unpublished and unusable research (Chalmers, Glasziou, Lancet 2009). As a family practitioner this work has particularly focused on the applicability and usability of published trials and reviews.

Professor Clara Chow AM is Academic Director of the Westmead Applied Research Centre (WARC), Faculty of Medicine and Health, University of Sydney. She is a cardiologist and Clinical Lead of Community Based Cardiac Services at Westmead hospital and is also a member of the Western Sydney Local Health District (WSLHD) Governing Board, Sydney, Australia. Professor Chow is Director of the Australian Stroke and Heart Accelerator (ASHRA) and was honoured with a Telstra Brilliant Woman in Digital Health Award in 2022 and is past-President of the Cardiac Society of Australia and New Zealand. Professor Chow’s research focuses on the prevention of cardiovascular disease, innovation in the delivery of cardiovascular care and the evaluation of digital health interventions.

Nicholas Cox is the Director of Cardiology at Western Health. He is Clinical Associate Professor, University of Melbourne; Board Member of the National Heart Foundation; and Interventional Cardiologist at Epworth Health Care. He is a Graduate Australian Institute of Company Directors; Fellow of the Cardiac Society of Australia and New Zealand and Fellow Royal Australian College of Physicians; He completed his MBBS University of Melbourne and Interventional and Research Cardiology Fellowship Brigham and Women’s Hospital, Boston MA. His interests include radial access coronary angiography, systems of care for patients with cardiogenic shock; new models of care for elderly patients with heart failure; and systems of care for patients undergoing coronary intervention.

Prof Mark Flynn is a Professor at the University of Newcastle and the Chief Audiology Officer at Sound Scouts. He is passionate for the development of innovative technology to assist people with hearing loss.

Mark has a PhD from the University of Melbourne, a dual MBAs from Georgetown University and ESADE, and won 22 individual and group prizes for his professional work. For his product innovation, he has been responsible for over 20 medical products and services, inventor of 17 international patents, author of over 100 publications, and raised over $74M in grant funding.

Danielle A. Wilhour, MD is an Assistant Professor of Neurology at the University of Colorado School of Medicine. After graduating from the University of Pennsylvania, she received her medical degree from Sidney Kimmel Medical School. She completed her Neurology residency and Headache Medicine fellowship at Thomas Jefferson University. Dr. Wilhour joined the faculty of the University of Colorado in 2019. She has contributed several papers to the field of headache medicine. Her primary interests include non-pharmacologic treatment of headache as well as headache during pregnancy. Devoted to teaching, she became Fellowship Director for the Headache section in 2022.

The overall goal of my present research work at the Kirby Institute is two-fold. Firstly to define the basic mechanisms of HIV spread, from tracking entry and fusion of single HIV virions through to the more logistically challenging task of tracking viral spread through cell-cell contact. To date our laboratory is one of only a few laboratories worldwide that can image HIV spread in live HIV infected primary cell types. The second component of my laboratory is currently involved and actively collaborating with research groups involved in using gene therapy for a treatment of a range of chronic diseases including HIV. Indeed a functional cure for HIV may lie in gene therapy. For instance, functional removal of human genes that HIV needs or attacking the viral genes directly, all represent ways to silence the viral reservoir in the long term. Whilst there are many approaches that work in cell line models, the present limitation to this approach is gene delivery. For instance the cells of the immune system that HIV attacks are unfortunately very difficult to deliver genes to. The broad aim of this project is to systematically determine the best protocol for gene delivery by using different combinations of viral proteins. We are actively looking for capable honours, masters and PhD students who have a strong interest in the intersection of virology and cellular biology to undertake NHMRC funded projects.

Prof Simon Willcock is a General Practitioner and the Clinical Director of Primary Care at MQ Health. His education and research interests include the health of doctors, low back pain, the early identification of dementia in the community, systems change in medical service delivery, and communication in medical practice. In addition to his Macquarie University role, Prof Willcock is Deputy Chair of the Sydney North Health Network and Chair of the Estia Health Clinical Governance Committee. His board roles have been in medical indemnity and health insurance, and roles in the Royal Australian College of General Practitioners and the Australian Medical Association.

Dr Li Ping Chung is a respiratory physician with special interests in severe airways disease including asthma, Chronic Obstructive Pulmonary Disease (COPD), and non-CF bronchiectasis. In 2013, Dr Chung completed her PhD, which focused on pharmacogenetics of severe asthma. In addition to her current role as the clinical lead for airways disease at Fiona Stanley Hospital, she is also involved in the development and expansion of community respiratory services by Silver Chain to better support patients with chronic respiratory diseases in the non-tertiary setting. Dr Chung is also involved in a number of NHMRC funded scientific and clinical research projects related to asthma and other airway disease. She is currently a member of the Thoracic Society of Australia and New Zealand (TSANZ) Research Subcommittee, TSANZ (WA Branch).

Associate Professor Deshan Sebaratnam completed his Bachelor of Medicine Bachelor of Surgery at UNSW, graduating with Honours. While completing his residency at Royal Prince Alfred Hospital, he also completed his Master of Medicine.
As part of his dermatology training with the Australasian College of Dermatologists, he was chosen to complete a Fellowship at St. John’s Institute for Dermatology in London.
He is a Staff Specialist at Liverpool Hospital. He has a strong interest research, having published his work in international medical journals and presented at conferences around the world. He is an academic at UNSW and USyd, regularly lecturing to medical students, doctors in training, GPs and other specialists.
Associate Professor Sebaratnam operates at The Skin Hospital, Westmead.

Professor Mark S Cooper is the Professor of Medicine and Head of Concord Clinical School. He also undertakes research at the ANZAC Research Institute and Concord Hospital. He is a leading expert in glucocorticoid metabolism and action particularly in relation to the effects of endogenous and therapeutic glucocorticoids on bone.
He is a board member of Healthy Bones Australia.

Nathan Cheetham is a quantitative researcher studying the long-term effects of the coronavirus pandemic on health. Nathan is focused on understanding the role of social factors on health outcomes in the United Kingdom.

Since 2021, Nathan has been at King’s College London, where he has worked with the TwinsUK and COVID Symptom Study Biobank studies, researching immune response to COVID vaccination and the long term effects of COVID infection on cognition and everyday functioning.

Nathan has a background in physical sciences, completing his MSci in Natural Sciences at Durham University in 2013. He then moved to Imperial College London where he earned his PhD in Physics in 2018, researching new materials for solar energy applications.

Following his PhD, Nathan moved to NHS North East London Clinical Commissioning Group in 2019, working as a data analyst and manager. During the coronavirus pandemic, Nathan developed a mathematical model to estimate the effects of easing restrictions on hospital admissions (Cheetham et al., Scientific Reports, 2021), created a interactive tool for senior leadership to track COVID-19, and joined the North East London vaccination program team to help set up and deliver COVID-19 vaccinations.
Experience